ArticleBMJ public health2026
Changes in the use of e-cigarettes to stop smoking among adults following the rise of disposable vapes: a repeat cross-sectional survey 2016-2023 in England.
Article in BMJ public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Using a representative repeat cross-sectional survey, we investigate how the prevalence of e-cigarette ('vape') use, prescription or specialist support and other (non-prescription or specialist support) methods in smoking quit attempts changed following growth in novel disposable vape use in England. Methods: 8323 adults (≥18 years; 47.5% women; mean (SD) age: 39.2 (15.5)) who smoked-and tried to quit-in the past year, were surveyed between July 2016 and December 2023. Using segmented regressions, we estimated annual trends in smoking quit attempts using (1) a vape, (2) prescription or specialist support and (3) other methods before ('pre-disposables') and after June 2021 ('post-disposables'). In a sensitivity analysis, we modelled changes in each outcome associated with the prevalence of disposable vaping as a continuous variable. Results: During the pre-disposables period, vape use in a quit attempt decreased by 3.1% per year (relative risk (RR)=0.969 (95% CI 0.927 to 1.012)). This trend reversed when disposables became popular (RR=1.20 (95% CI 1.12 to 1.29)), with a relative year-on-year increase in prevalence of 16.5% from June 2021 (from 27.7% in June 2021 to 40.6% in December 2023). Conversely, use of other (non-prescription or specialist support) methods increased by 3.6% per year (RR=1.036 (95% CI 1.01 to 1.06)) before June 2021, before reversing (RR=0.91 (95% CI 0.88 to 0.95)) into a relative yearly decline in prevalence of 5.6% (from 65.4% to 56.6%). Use of prescription/specialist support declined by 12% per year (RR=0.880 (95% CI 0.802 to 0.966)) before June 2021, and there was no apparent change in trend. In aggregate models, for each percentage-point increase in disposable vaping, vape use in a quit attempt (in the subsequent month) rose by ~0.66 percentage points (95% CI 0.05 to 1.26), while use of other methods declined by 0.82 percentage points (95% CI -1.40 to -0.24). Conclusions: Increasing use of disposable vapes in England was associated with increased vape use and decreased use of other (non-prescription or specialist support) methods in smoking quit attempts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.